GMO Pepabo, Inc.(3633) News

[Summary]Consolidated Financial Results for the Fiscal Year Ended December 31, 2025[Japanese GAAP]

GMO Pepabo, 15% Decrease in Ordinary Profit for The Current Fiscal Year

GMO Pepabo, Net Income Forecast for the Fiscal Year Revised Upward by 10%, Highest in Five Terms, Dividend Revised Upward by 9 Yen

[Summary]Consolidated Financial Results for the Nine Months Ended September 30, 2025[Japanese GAAP]

GMO Pepabo, Ordinary Profit Forecast for the Fiscal Year Revised Upward to an Unexpected 27% Increase, Highest in Five Terms, Dividend Revised Upward by 29 Yen

[Summary]Consolidated Financial Results for the Six Months Ended June 30, 2025[Japanese GAAP]

GMO Pepabo, First Half Ordinary Profit Increases by 13%

GMO Pepabo, Jan-Mar (1Q) Ordinary Profit Increases by 31%

[Summary]Consolidated Financial Results for the Three Months Ended March 31, 2025[Japanese GAAP]

[Summary]Consolidated Financial Results for the Fiscal Year Ended December 31, 2024[Japanese GAAP]

GMO Pepabo, 8% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 4 yen, This Fiscal Year to Increase Dividend by 10 yen

GMO Pepabo, Inc., The Current Fiscal Year Ordinary Profit Revised Upward by 24%, Dividend Revised Upward by 13 yen

[Summary]Consolidated Financial Results for the Nine Months Ended September 30, 2024[Japanese GAAP]

Notice of Revisions to Consolidated Financial Results Forecast and Year-end Dividend Forecast (Dividend Increase)